It may surprise many to hear that some of today’s most advanced treatments, such as cell therapies for cancer, diabetes, and autoimmunity, depend on flow cytometry — a 50-year old technology.

October is Breast Cancer Awareness Month, and fittingly, University of New Mexico Comprehensive Cancer Center biologist Curt ...

SAN ANTONIO, October 16, 2024--(BUSINESS WIRE)--bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts ...

“Our CyPath® Lung noninvasive test for the early detection of lung cancer is a novel test that uses sputum, a unique sample type that is not typically used in clinical flow cytometry assays ...

A new immune cell biomarker has been discovered that can predict the effectiveness of immune anticancer treatment in patients ...

We performed integration-site analysis, genetic studies, flow cytometry, and morphologic studies ... features of seven cases of hematologic cancer (as of April 25, 2024) in patients who received ...

(2024-10-16 | NDAQ:BIAF) bioAffinity's CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines ...

Spectral flow cytometry collects the full emission spectrum of a fluorochrome, enabling multicolor panels with more parameters than conventional flow cytometry. As scientists discover the subtle ...